564 related articles for article (PubMed ID: 27995060)
1. Hippocampal volume predicts antidepressant efficacy in depressed patients without incomplete hippocampal inversion.
Colle R; Cury C; Chupin M; Deflesselle E; Hardy P; Nasser G; Falissard B; Ducreux D; Colliot O; Corruble E
Neuroimage Clin; 2016; 12():949-955. PubMed ID: 27995060
[TBL] [Abstract][Full Text] [Related]
2. Smaller hippocampal volumes predict lower antidepressant response/remission rates in depressed patients: A meta-analysis.
Colle R; Dupong I; Colliot O; Deflesselle E; Hardy P; Falissard B; Ducreux D; Chupin M; Corruble E
World J Biol Psychiatry; 2018 Aug; 19(5):360-367. PubMed ID: 27376473
[TBL] [Abstract][Full Text] [Related]
3. Abnormal Hippocampal Subfields May Be Potential Predictors of Worse Early Response to Antidepressant Treatment in Drug-Naïve Patients With Major Depressive Disorder.
Hu X; Zhang L; Hu X; Lu L; Tang S; Li H; Bu X; Gong Q; Huang X
J Magn Reson Imaging; 2019 Jun; 49(6):1760-1768. PubMed ID: 30295348
[TBL] [Abstract][Full Text] [Related]
4. Depressed suicide attempters have smaller hippocampus than depressed patients without suicide attempts.
Colle R; Chupin M; Cury C; Vandendrie C; Gressier F; Hardy P; Falissard B; Colliot O; Ducreux D; Corruble E
J Psychiatr Res; 2015 Feb; 61():13-8. PubMed ID: 25555305
[TBL] [Abstract][Full Text] [Related]
5. Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression.
Maller JJ; Broadhouse K; Rush AJ; Gordon E; Koslow S; Grieve SM
Mol Psychiatry; 2018 Aug; 23(8):1737-1744. PubMed ID: 29133948
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal volume as treatment predictor in antidepressant naïve patients with major depressive disorder.
Zarate-Garza PP; Ortega-Balderas JA; Ontiveros-Sanchez de la Barquera JA; Lugo-Guillen RA; Marfil-Rivera A; Quiroga-Garza A; Guzman-Lopez S; Elizondo-Omaña RE
J Psychiatr Res; 2021 Aug; 140():323-328. PubMed ID: 34126427
[TBL] [Abstract][Full Text] [Related]
7. A Prospective, Longitudinal Study of the Effect of Remission on Cortical Thickness and Hippocampal Volume in Patients with Treatment-Resistant Depression.
Phillips JL; Batten LA; Tremblay P; Aldosary F; Blier P
Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25829180
[TBL] [Abstract][Full Text] [Related]
8. Structural Changes in Hippocampal Subfields in Patients with Continuous Remission of Drug-Naive Major Depressive Disorder.
Katsuki A; Watanabe K; Nguyen L; Otsuka Y; Igata R; Ikenouchi A; Kakeda S; Korogi Y; Yoshimura R
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344826
[TBL] [Abstract][Full Text] [Related]
9. Early response and remission as predictors of a good outcome of a major depressive episode at 12-month follow-up: a prospective, longitudinal, observational study.
Ciudad A; Álvarez E; Roca M; Baca E; Caballero L; García de Polavieja P; Casillas M; Valladares A; Gilaberte I
J Clin Psychiatry; 2012 Feb; 73(2):185-91. PubMed ID: 22053897
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report.
Nogovitsyn N; Muller M; Souza R; Hassel S; Arnott SR; Davis AD; Hall GB; Harris JK; Zamyadi M; Metzak PD; Ismail Z; Downar J; Parikh SV; Soares CN; Addington JM; Milev R; Harkness KL; Frey BN; Lam RW; Strother SC; Rotzinger S; Kennedy SH; MacQueen GM
Neuropsychopharmacology; 2020 Jan; 45(2):283-291. PubMed ID: 31610545
[TBL] [Abstract][Full Text] [Related]
11. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
[TBL] [Abstract][Full Text] [Related]
12. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.
Miller JM; Oquendo MA; Ogden RT; Mann JJ; Parsey RV
J Psychiatr Res; 2008 Oct; 42(14):1137-44. PubMed ID: 18331740
[TBL] [Abstract][Full Text] [Related]
13. Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder.
Korgaonkar MS; Rekshan W; Gordon E; Rush AJ; Williams LM; Blasey C; Grieve SM
EBioMedicine; 2015 Jan; 2(1):37-45. PubMed ID: 26137532
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal volume and the rapid antidepressant effect of ketamine.
Abdallah CG; Salas R; Jackowski A; Baldwin P; Sato JR; Mathew SJ
J Psychopharmacol; 2015 May; 29(5):591-5. PubMed ID: 25122038
[TBL] [Abstract][Full Text] [Related]
15. Incomplete Hippocampal Inversion and Its Relationship to Hippocampal Subfield Volumes and Aging.
Colenutt J; McCann B; Knight MJ; Coulthard E; Kauppinen RA
J Neuroimaging; 2018 Jul; 28(4):422-428. PubMed ID: 29575376
[TBL] [Abstract][Full Text] [Related]
16. Disrupted topology of hippocampal connectivity is associated with short-term antidepressant response in major depressive disorder.
Gong L; Hou Z; Wang Z; He C; Yin Y; Yuan Y; Zhang H; Lv L; Zhang H; Xie C; Zhang Z
J Affect Disord; 2018 Jan; 225():539-544. PubMed ID: 28866298
[TBL] [Abstract][Full Text] [Related]
17. State dependent posterior hippocampal volume increases in patients with major depressive disorder.
Schermuly I; Wolf D; Lieb K; Stoeter P; Fellgiebel A
J Affect Disord; 2011 Dec; 135(1-3):405-9. PubMed ID: 21849213
[TBL] [Abstract][Full Text] [Related]
18. Early life adversity is associated with a smaller hippocampus in male but not female depressed in-patients: a case-control study.
Colle R; Segawa T; Chupin M; Tran Dong MN; Hardy P; Falissard B; Colliot O; Ducreux D; Corruble E
BMC Psychiatry; 2017 Feb; 17(1):71. PubMed ID: 28202012
[TBL] [Abstract][Full Text] [Related]
19. The association between gray matter volume in the hippocampal subfield and antidepressant efficacy mediated by abnormal dynamic functional connectivity.
Kuai C; Pu J; Wang D; Tan Z; Wang Y; Xue SW
Sci Rep; 2024 Apr; 14(1):8940. PubMed ID: 38637536
[TBL] [Abstract][Full Text] [Related]
20. Hippocampal N-acetylaspartate and morning cortisol levels in drug-naive, first-episode patients with major depressive disorder: effects of treatment.
Wang Y; Jia Y; Chen X; Ling X; Liu S; Xu G; Huang L
J Psychopharmacol; 2012 Nov; 26(11):1463-70. PubMed ID: 22706518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
